Cory Calendine, MD to Demonstrate and Discuss Using the Avail System at AAOS 2021 Annual Meeting

August 30, 2021

SANTA CLARA, Calif. – August 30, 2021 /OrthoSpineNews/ – Cory Calendine, MD, a board-certified orthopaedic surgeon specializing in anterior hip replacement, robotic joint replacement, and partial and total hip and knee replacement at the Bone and Joint Institute of Tennessee, will discuss use cases and provide demonstrations of the Avail remote collaboration technology system during the AAOS 2021 Annual Meeting. Avail Medsystems’ uniquely immersive audio/visual hardware and software technology enables surgeons to collaborate, consult and educate with remote physicians and medical device experts in real time. The AAOS meeting takes place September 1-3, 2021 in San Diego, California and features the most comprehensive level of education and research from today’s orthopaedic world leaders.

WHO:	Cory Calendine, MD
WHAT:	Discussion of Cases and Demonstrations Using the Avail System
WHEN:	Wednesday, September 1: 2-3 PM PDT Thursday, September 2: 10-11 AM PDT
WHERE:	Avail Medsystems Booth #4441
WHY:	Dr. Calendine will be in the Avail Medsystems’ booth to discuss how and why he uses the Avail remote medical collaboration technology system. Calendine will also conduct demonstrations of the Avail System in the booth. Visitors to the booth will also be able to put their hands on the Avail System with iPad and laptop stations to test out the Avail Console on the show floor, and virtually in the new state-of-the-art demo room at Avail’s HQ in Santa Clara, CA.

# # #

Avail Medsystems is a pioneering medical technology company that removes the collaborative barriers associated with in-person medical procedures. With a customer-centric business model, Avail’s purpose-built technology digitizes physical presence in the procedure room and enables on-the-go, HIPAA-compliant collaboration among a network of healthcare professionals and industry experts. For more information about Avail Medsystems, visit Avail.io and follow us on Twitter, Facebook, Instagram and LinkedIn.